1
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Response to Brewer

Pages 448-449 | Published online: 12 Jul 2009

References

  • Mattick R P, Ali R, White J M, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003; 98: 441–452
  • Mattick R P, Digiusto E, Doran C, et al. NEPOD Trial Investigators. National evaluation of pharmacotherapies for opiod dependence (NEPOD). Australian Government Department of Canberra: Health and Ageing. 2001
  • Digiusto E, Lintzeris N, Breen C, et al. NEPOD Research Group. Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project. Addict Behav 2005; 30: 443–456
  • Mattick R P, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003; 2, CD002209
  • Mattick R P, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2003; 2, CD002207
  • Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users. Cambridge University Press, Melbourne 2007
  • Degenhardt L, Gibson A, Hall W, Mattick R P. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Drug Alcohol Rev 2008; 27: 1–3
  • Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2003; 2, CD001333
  • Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick R P. NEPOD Research Group. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction 2004; 99: 450–460
  • Tucker T K, Ritter A J, Maher C, Jackson H. Naltrexone maintenance for heroin dependence: uptake, attrition and retention. Drug Alcohol Rev 2004; 23: 299–309
  • Comer S, Sullivan M, Yu E, et al. Response to ‘Lack of information in naltrexone study’. Arch Gen Psychiatry 2007; 64: 865
  • Gibson A, Degenhardt L, Hall W. Opioid deaths can occur in patients with naltrexone implants. Med J Aust 2007; 186: 152–153
  • House of Representatives Standing Committee on Family and Human Services. The winnable war on drugs: the impact of illicit drug use on families. Canberra: Parliament of the Commonwealth of Australia, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.